- Business Model
- B2B
- Website
- sidewinderbio.com
- Total Funding
- $137.0M
- Last Round
- $137.0M Series B
- Rounds
- 1
About
Pioneering the next generation of large molecule precision therapeutics to deliver new life-saving therapies for cancer patients.
Summary
Sidewinder Therapeutics is a Biotech company based in United States. It has raised $137.0M in total across 1 round.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Similar Companies
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform